# Clinical Cases: Nervous Tissue - Glial Cells ## Case 1: Multiple Sclerosis ### Clinical Image ![Multiple Sclerosis - Brain MRI](case_01_image.jpg) *Source: [Radiopaedia - Multiple Sclerosis](https://radiopaedia.org/articles/multiple-sclerosis) - CC BY-NC-SA 3.0* ### Case Presentation A 28-year-old woman presents with a 3-day history of blurred vision and pain with eye movement in her right eye. Two years ago, she had an episode of numbness and tingling in her legs that resolved spontaneously over several weeks. Neurological examination reveals a right relative afferent pupillary defect, decreased visual acuity (20/100), and impaired color vision. Fundoscopy shows mild optic disc swelling. MRI of the brain reveals multiple T2-hyperintense lesions in periventricular white matter with a characteristic "Dawson fingers" pattern (ovoid lesions perpendicular to the ventricles along the path of perivenular veins). Several lesions enhance with gadolinium, indicating active inflammation. MRI of the spine shows a demyelinating lesion in the cervical cord. Cerebrospinal fluid analysis reveals oligoclonal bands. She is diagnosed with relapsing-remitting multiple sclerosis. The pathophysiology involves autoimmune attack on oligodendrocytes and myelin in the CNS. Oligodendrocytes, each of which myelinates segments of up to 50 different axons, are destroyed, leading to demyelinated plaques and impaired saltatory conduction. She is treated with high-dose IV corticosteroids and started on disease-modifying therapy. ### Key Learning Points - Multiple sclerosis is an autoimmune inflammatory disease targeting oligodendrocytes and CNS myelin - Oligodendrocytes each myelinate segments of multiple axons; their destruction produces widespread demyelination - Loss of myelin disrupts saltatory conduction, slowing or blocking nerve impulse transmission - CNS myelin has very limited regenerative capacity, so disability accumulates over time - Understanding oligodendrocyte function (myelination of multiple axon segments) explains why focal inflammation produces widespread effects --- ## Case 2: Glioblastoma ### Clinical Image ![Glioblastoma - Brain MRI](case_02_image.jpg) *Source: [Wikipedia - Glioblastoma](https://en.wikipedia.org/wiki/Glioblastoma) - CC BY-SA 3.0* ### Case Presentation A 62-year-old man presents with a 6-week history of progressive headache, confusion, and left-sided weakness. His wife reports personality changes with apathy and poor judgment. Neurological examination reveals left hemiparesis, left homonymous hemianopia, and expressive aphasia. MRI brain reveals a large, heterogeneous, ring-enhancing mass in the right frontotemporal region with central necrosis, surrounding vasogenic edema, and mass effect with midline shift. The enhancement pattern reflects breakdown of the blood-brain barrier due to abnormal tumor vasculature. Stereotactic biopsy is performed. Histopathology shows markedly pleomorphic cells with nuclear atypia, high mitotic activity, microvascular proliferation, and areas of pseudopalisading necrosis (tumor cells arranged around necrotic foci) - all hallmarks of glioblastoma. GFAP immunostaining is positive, confirming astrocytic origin. Molecular testing shows IDH-wildtype status. The diagnosis is glioblastoma (WHO grade 4). Despite aggressive treatment with surgery, radiation, and temozolomide chemotherapy, the prognosis is poor with median survival of approximately 15 months. ### Key Learning Points - Glioblastoma arises from astrocytes, identified by GFAP (glial fibrillary acidic protein) expression - The tumor's aggressive behavior reflects rapid proliferation and neovascularization with abnormal blood-brain barrier - Pseudopalisading necrosis (viable tumor cells surrounding necrotic areas) is a histological hallmark - The blood-brain barrier, normally maintained by astrocyte end-feet and specialized endothelium, breaks down in tumors - Understanding astrocyte markers (GFAP) and function (blood-brain barrier maintenance) is essential for tumor classification --- ## Case 3: Guillain-Barre Syndrome ### Clinical Image ![Guillain-Barre Syndrome - Demyelination](case_03_image.jpg) *Source: [Wikipedia - Guillain-Barre Syndrome](https://en.wikipedia.org/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome) - CC BY-SA 3.0* ### Case Presentation A 45-year-old man presents with rapidly progressive weakness that began in his feet 4 days ago and has now ascended to involve his thighs. He had a diarrheal illness 2 weeks prior. Neurological examination reveals symmetric, flaccid weakness more prominent distally, absent deep tendon reflexes (areflexia), and mild sensory loss in a stocking distribution. He has difficulty taking a deep breath (vital capacity 50% of predicted), indicating respiratory muscle involvement. Cerebrospinal fluid analysis shows albuminocytologic dissociation (elevated protein with normal cell count). Nerve conduction studies reveal severely reduced conduction velocities and conduction block, consistent with demyelination. He is diagnosed with Guillain-Barre syndrome (GBS), an acute inflammatory demyelinating polyneuropathy. The pathophysiology involves autoantibodies (often triggered by preceding infection with Campylobacter jejuni) attacking Schwann cells and peripheral myelin. Unlike MS affecting the CNS, GBS has a relatively good prognosis because Schwann cells can proliferate and remyelinate peripheral axons. He is treated with IV immunoglobulin and requires temporary mechanical ventilation. He recovers substantially over several months. ### Key Learning Points - GBS targets Schwann cells and peripheral myelin, in contrast to MS which targets oligodendrocytes and CNS myelin - Each Schwann cell myelinates only one segment of one axon (unlike oligodendrocytes that myelinate multiple axons) - The PNS has much greater regenerative capacity than the CNS because Schwann cells proliferate and form bands of Bungner to guide remyelination - Schwann cells are surrounded by basal lamina; these basal lamina tubes persist after injury and guide regenerating axons and remyelinating Schwann cells - Understanding the difference between CNS and PNS myelination explains the different prognoses of MS versus GBS --- ## Summary: Glial Cell Disorders These cases demonstrate how understanding glial cell biology informs clinical practice: | Disorder | Glial Cell Affected | Location | Regenerative Capacity | Prognosis | |----------|--------------------|---------|-----------------------|-----------| | **Multiple Sclerosis** | Oligodendrocytes | CNS | Very limited | Progressive disability | | **Glioblastoma** | Astrocytes (neoplastic) | CNS | N/A (tumor) | Poor (median 15 months) | | **Guillain-Barre Syndrome** | Schwann cells | PNS | Good (proliferate, remyelinate) | Generally good recovery | The key distinction between CNS and PNS myelination - oligodendrocytes (multiple axon segments per cell, no basal lamina, limited regeneration) versus Schwann cells (one segment per cell, basal lamina present, robust regeneration) - explains critical differences in disease outcomes.